Le Lézard
Classified in: Health
Subject: NPT

AMCP Nexus 2017 Draws Nearly 2,500 Managed Care Pharmacy Professionals for Conference Themed 'Changing the Way We Pay for Health Care'


ALEXANDRIA, Va., Oct. 20, 2017 /PRNewswire-USNewswire/ -- Nearly 2,500 managed care pharmacy professionals from across the country gathered in the heart of Texas this week for dozens of educational sessions and discussions on how to boost outcomes and control costs for the roughly 270 million Americans covered by a managed pharmacy benefit.

Academy of Managed Care Pharmacy. (PRNewsFoto/Academy of Managed Care Pharmacy)

The Academy of Managed Care Pharmacy held its AMCP Nexus 2017 conference, Oct. 16-19 at the Gaylord Texan Hotel & Convention Center in Grapevine, Texas, near Dallas. The theme of this year's event was "changing the way we pay for health care."

Stakeholders from across the health care system are looking for new ways to improve the value and outcomes of care while bending the cost curve, said AMCP CEO Susan A. Cantrell, RPh, CAE.

"AMCP is proud to be at the forefront of innovative efforts to reexamine how we pay for care, including through promising value-based contracts and other innovative payment models," she said. "This conference draws national thought leaders who are providing actionable insights into these and other issues that will improve our health care system now and in the future."

AMCP Nexus 2017 featured more than 30 educational sessions in five tracks: (1) Changing the Way We Pay for Health Care; (2) Drugs, Diseases and the Managed Care Impact; (3) Legislative and Regulatory Trends: From Rhetoric to Practice; (4) Managed Care Research in Action; and (5) Specialty Pharmacy Management: Keeping Up with Runaway Innovation.

The General Session featured a keynote panel of national experts who discussed innovative ways in which to pay for the wave of remarkable, yet high-cost curative therapies coming to market.

In addition, Nexus 2017 included 11 satellite symposia on diverse issues affecting health care; an Exchange hall featuring more than 40 exhibitors presenting the latest ideas, tools and advancements; a slate of Science & Innovation Theaters and Industry Workshops providing additional education on managed care pharmacy issues; and various programming designed specifically for student pharmacists. Nexus 2017 also included the AMCP Foundation's 7th Annual Research Symposium titled "Value Based Health Care: Identifying Benefits for Patients, Providers and Payers."

About AMCP  
The Academy of Managed Care Pharmacy (AMCP) is a national professional association of pharmacists, physicians, nurses and other health care practitioners who serve society by applying sound medication management principles and strategies to improve health care. The Academy's 8,000 members provide clinical, medication, educational, and business management services on behalf of the nearly 270 million Americans covered by a managed care pharmacy benefit. www.amcp.org

 

SOURCE Academy of Managed Care Pharmacy


These press releases may also interest you

at 18:30
Striking Teamsters at pharmaceutical giant Cencora (formerly known as AmerisourceBergen) rallied today outside the company's Sacramento distribution center. The 124 warehouse workers are members of Teamsters Local 150 and have been on strike since...

at 18:00
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen's Lab at Emory University School of Medicine....

at 17:58
More than 200 workers at American Medical Response (AMR) in Springfield and Greenfield have voted overwhelmingly to join Teamsters Local 404....

at 17:54
The American Association of Kidney Patients (AAKP), the largest and oldest independent kidney patient organization in the nation, is celebrating National Doctors Day by highlighting three top kidney medical experts and authors known for their...

at 17:20
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted an inducement award on March 28, 2024. One individual was...

at 17:15
Paladin Labs Inc., a subsidiary of Endo International plc , today announced Health Canada's approval of WAKIX® (pitolisant hydrochloride tablets) for the treatment of excessive daytime sleepiness (EDS) or cataplexy in pediatric patients aged 6 years...



News published on and distributed by: